“Investigators from the C.S. Mott Center for Human Growth and Development at the Wayne State University School of Medicine reported today in Cancer Immunology Research the characterization of a novel therapeutic approach capable of restoring immune surveillance and providing long-term protection against ovarian cancer tumors…”
“Dr. Gil More and Dr. Gloria Huang from Yale New Haven Hospital joined Zagger at the Monday ceremony. Mor said advances are being made because doctors no longer approach ovarian cancer as a single disease but as several diseases, allowing for a better understanding of the treatment…”
“For many years, the process of pregnancy was likened to that of organ transplantation, as Dr. Gil Mor – a professor of obstetrics, gynecology, and reproductive sciences at Yale School of Medicine in New Haven, CT – and colleagues explain in a recent article Trusted Source published in the journal Nature Reviews Immunology…”
“Dr. Gil G. Mor, the director of reproductive sciences at Yale University School of Medicine, said that scientists should not rule out the possibility that the Zika virus caused damage without ever infecting fetuses…”
“Dr. Gil Mor, Director of Reproductive Sciences in the Department of Obstetrics, Gynecology and Reproductive Sciences at Yale School of Medicine, introduced this year’s five grant recipients funded by Discovery to Cure…”
“The scientific director of the Wayne State University School of Medicine’s C.S. Mott Center for Human Growth and Development has launched a study funded by the National Institutes of Health to examine the impact volatile organic compounds have on early development of the fetal immune system.
Principal investigator Gil Mor, M.D., Ph.D., will use a three-year, $ 1,140,311 grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development on the project, “Impact of benzene-induced MIA on fetal T cell development…”
“A doctoral student in the Wayne State University School of Medicine’s Department of Physiology won the Three-Minute Thesis Competition, held March 8 at the 2023 WSU Graduate Research Symposium.
Nicholas Adzibolosu’s presentation, “Developing Personalized Medicine for Ovarian Cancer,” won him a spot to represent Wayne State in the Midwestern Association of Graduate Schools Three-Minute Thesis Competition, to be held March 31 in Chicago.
Participants in Three-Minute Thesis, or 3MT, present their research in a compelling oration of three minutes or less using a single slide. The winner is decided by the audience. The competition was created by the University of Queensland in 2008…”
“A Wayne State University School of Medicine professor has edited a new book that introducing immunological aspects of pregnancy complications.
“Reproductive Immunology: Basic Concepts,” edited by Gil Mor, M.D., Ph.D., director of the C.S. Mott Center for Human Growth and Development and John M. Malone Jr., M.D., Endowed Professor of Obstetrics and Gynecology, is now available. Dr. More is also interim chair of the Department of Physiology…”
“CaroGen Corp., in collaboration with a team of scientists at the C.S. Mott Center for Human Growth and Development at the Wayne State University School of Medicine, this week announced that it has made significant progress in developing CARG-2020 for potential treatment of patients with ovarian cancer and other peritoneal tumors.
“We have shown through a number of in vitro and in vivo experiments that CARG-2020-delivering multiple immunomodulators induce broad spectrum immune responses, resulting in prevention of tumor recurrence and curing the mice with ovarian cancer…”
“The C.S. Mott Center for Human Growth and Development at the Wayne State University School of Medicine has teamed with the Institute of Reproductive Health of Tongji Medical College at Huazhong University of Science and Technology in Wuhan, China, to establish the International Women Health Research Program.
The goal of the new collaboration is to improve women’s treatment and care, particularly in the areas of cancer and reproductive health…”
“Advaita Bioinformatics, an Ann Arbor-based company spun out of Wayne State University, announced that it has identified methylprednisolone, a generic FDA-approved corticosteroid typically used to treat inflammation and other common ailments, as a drug that can improve outcomes for patients critically ill with COVID-19…”
“Gil Mor, scientific director of the C.S. Mott Center for Human Growth and Development and vice chair of research in the Department of Obstetrics and Gynecology, proposes development of an anti-viral therapy to prevent COVID-19 infection during pregnancy. The proposed therapeutic approach is based on the identification of a natural component of the cellular anti-viral response that can stop viral expansion and/or prevent infection during pregnancy. The study’s outcome will enhance the understanding of the complexity of immune regulation at the maternal/fetal interface, but also will provide novel opportunities for the identification of predictive markers and new therapeutic approaches…”
“The Wayne State University School of Medicine has named a new scientific director of the C.S. Mott Center for Human Growth and Development.
Gil Mor, M.D., Ph.D., who is joining the WSU faculty from Yale University, will serve as John M. Malone Jr., M.D., Endowed Chair and scientific director of the center. His appointment was effective Dec. 6.
“We are indeed fortunate to have a world-renowned physician and researcher of Dr. Mor’s status join our faculty and lead the C.S. Mott Center for Human Growth and Development,” Dean Jack D. Sobel, M.D., and Chaur-Dong Hsu, M.D., M.P.H., FACOG, chair of the WSU Department of Obstetrics and Gynecology, wrote in the joint announcement of Dr. Mor’s appointment…”